{"id":"W4288045904","doi":"10.1016/j.ijcard.2022.07.017","title":"Translating results from the cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists into clinical practice: Recommendations from a Eastern and Southern Europe diabetes expert group","year":2022,"lang":"en","type":"article","venue":"International Journal of Cardiology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Bausch Health; Mylan; Kowa Company; Novo Nordisk; Sanofi; AstraZeneca; Eli Lilly and Company; Servier; Amgen","keywords":"Medicine; Liraglutide; Dulaglutide; Semaglutide; Glucagon-like peptide 1 receptor; Incretin; Glucagon-like peptide-1; Type 2 Diabetes Mellitus; Internal medicine; Clinical trial; Type 2 diabetes; Diabetes mellitus; Exenatide; Endocrinology; Receptor; Agonist","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.3535115,0.004042005,0.01323568,0.005913978,0.002592076,0.02212529,0.01476127,0.02252178,0.004959943],"category_scores_gemma":[0.532748,0.002642732,0.01224506,0.007042023,0.005249702,0.01094852,0.009690866,0.03135693,0.005198659],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006133942,"about_ca_system_score_gemma":0.04137278,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01195131,"about_ca_topic_score_gemma":0.01851432,"domain_scores_codex":[0.7280323,0.1559031,0.07132402,0.008245902,0.03179878,0.004695838],"domain_scores_gemma":[0.3691309,0.3894538,0.04130634,0.01943259,0.165951,0.01472531],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004537284,0.0006444303,0.01018194,0.03455306,0.01176644,0.0004906459,0.002912989,0.002261612,0.001288741,0.01203424,0.4497001,0.4696285],"study_design_scores_gemma":[0.02259493,0.002395231,0.03070529,0.240173,0.03722369,0.0005093369,0.004155957,0.004832274,0.003219369,0.06350764,0.5896689,0.001014408],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.002718082,0.105441,0.01401856,0.8298963,0.03199098,0.002265407,0.002987954,0.0004749502,0.01020669],"genre_scores_gemma":[0.05448094,0.1377193,0.1997022,0.550522,0.0383151,0.00719314,0.005954395,0.001239878,0.004873029],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.3535115,"threshold_uncertainty_score":0.7972354,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05594745286082843,"score_gpt":0.3558025854240979,"score_spread":0.2998551325632695,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}